CFSAN-2022-112374 DFPST ICP-OES (Inductively Coupled Plasma - Optical Emission Spectrometry), plus four (4) option years of Preventative Maintenance Agreement (PMA)
Overview
- Response deadline
- 12:00 PM UTC−04:00
- Posted
- July 27, 2022
- Notice type
- Combined Synopsis/Solicitation
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA Office of Acquisitions and Grants Services
- Place of performance
- Summit Argo, IL, 60501
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- FDA-RFQ-CFSAN-2022-112374
- Notice ID
- 9798b1f6cca34324bb3587e27c903206
Description
The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure an ICP-OES (Inductively Coupled Plasma - Optical Emission Spectrometry), plus four (4) option years of Preventative Maintenance Agreement (PMA), under solicitation FDA-RFQ-CFSAN-2022-112374, per attached solicitation.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
FDA-RFQ-CFSAN-2022-112374- Combined Synopsis
- Combined SynopsisCurrentJul 27, 2022
CFSAN-2022-112374 DFPST ICP-OES (Inductively Coupled Plasma - Optical Emission Spectrometry), plus four (4) option years of Preventative Maintenance Agreement (PMA)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
FDA-RFQ-CFSAN-2022-112374
Archive Date
Aug 25, 2022
Office Address
Rockville, MD, 20857